From the Sector

• Solvay’s FY 2023 financial statements reflect the Partial Demerger completed on December 9, 2023, with the Specialty businesses transferred to Syensqo classified as discontinued operations for 2023.
• New Solvay leadership team committed to drive the transformation of the company.
• Net sales for the full year 2023 at €4,880 million were down -12.6% organically versus 2022, driven primarily by volume declines. In Q4, net sales decreased organically by -18.9% from both lower volumes and prices.
• Underlying EBITDA of €1,246 million for the full year 2023 was stable (+0.2%) on an organic basis compared to a record 2022, with positive Net Pricing and lower fixed costs offsetting the drop in volumes. EBITDA in the fourth quarter was down -24.5% organically vs Q4 2022, fully driven by lower volumes, with variable costs reduction offsetting price erosion, while fixed costs decreased slightly.
• Underlying net profit from continuing operations was €588 million in 2023 compared to €740 million in 2022.
• Free Cash Flow of €561 million in 2023 (+17.3% vs. €479 million in 2022) resulting in a record FCF conversion ratio of 45.4%, thanks to the strong EBITDA performance and to the positive impact from working capital variation.
• ROCE was 20.4% in 2023, -2.5pp compared to 2022 as a result of lower profit.
• Solid balance sheet at the end of December 2023, in line with the target capital structure announced in November 2023, with an underlying net debt of €1.5 billion, which translates into a leverage ratio of 1.2x.
• Total proposed gross dividend of €2.43 per share, subject to shareholders’ approval during the next Ordinary General Meeting of May 28, 2024.
• Solvay continues to reduce its GHG emissions (-19% vs 2021, scope 1 and 2).
• 2024 Outlook: Organic growth of the underlying EBITDA of -10% to -20% compared to restated 2023; Free cash flow of minimum €260 million

2024 outlook
Across its product portfolio, Solvay expects current demand levels to continue over the next few months and, as such, expects H1 2024 volumes to be broadly in line with H2 2023. At this point, there is little visibility on the second half of the year, however there are signs that the trend in the second half could improve. Solvay expects Soda Ash prices over FY 2024 to be lower than FY 2023, consistent with the current market environment, which will affect the business margin in 2024. Pricing trends across Solvay’s other businesses are forecasted to be more resilient year on year.

Lower energy and raw materials prices should offset some of the negative pressure on the topline. More importantly, Solvay has started to implement cost savings initiatives that will start to deliver results in 2024.

For full year 2024, Solvay expects an organic growth of the underlying EBITDA by -10% to -20% versus a high comparison base in 2023, especially in H1. This translates into a range of €925 million to €1,040 million at a 1.10 EUR/USD exchange rate.

The organic growth of the underlying EBITDA is calculated from a 2023 restated figure of €1,154 million (vs a reported figure of €1,246 million).

Free cash flow to Solvay shareholders from continuing operations is expected to be greater than €260 million, in line with the cash usage prioritization presented during the Capital Market Day in November 2023. It is supported by Solvay’s ability to manage its capex and working capital to ensure the financing of its businesses and the payment of dividends while keeping the strength of its balance sheet intact.

Solvay remains committed to implement its strategic roadmap and reconfirms its 2028 targets as communicated at the Capital Markets Day of November 2023.

• EBITDA of around EUR 300 million expected for 2023
• Non-cash impairment losses of up to EUR 480 million
• Implementation of the performance program fully on track

The annual valuation of assets in accordance with IFRS for the entire Lenzing Group both nationally in Austria and internationally, has resulted in a projected asset impairment of up to EUR 480 million for the 2023 financial year.¹ The reasons for the impairment requirements are, on the one hand, continued uncertainties in the economic environment and, on the other hand, still increased raw material and energy costs as well as a higher interest rate environment.

The impairment losses are non-cash effective and have no impact on the full-year EBITDA for 2023, but do affect EBIT for the 2023 financial year. The Managing Board is specifying the previous earnings forecast for the 2023 financial year (EBITDA: EUR 270 – 330 million) and expects an EBITDA of around EUR 300 million.

Stephan Sielaff, Chief Executive Officer of the Lenzing Group: “In the third quarter of 2023, we responded to the persistently difficult market environment and launched a comprehensive performance program, which we have been consistently implementing since then with a focus on positive free cash flow and stronger sales and margin growth. We can therefore confirm our earnings forecast with an EBITDA of around EUR 300 million. The valuation adjustment in accordance with IFRS does not change the strategic orientation of the Lenzing Group.”

Nico Reiner, Chief Financial Officer, adds: “The implementation of the performance program is going according to plan. In the future, cost measures alone are expected to contribute more than EUR 100 million to earnings annually, of which more than EUR 50 million will already be effective for the 2024 financial year. We are on target, particularly in terms of strengthening free cash flow, and we also achieved positive free cash flow in the fourth quarter. The revaluation of assets is now consistent and the right step for the future direction.”

The 2023 annual results will be presented on March 15, 2024.
 

¹ Subject to potential changes resulting from the ongoing financial audit

The mission of Accelerating Circularity is to create new supply chains and business models to turn textile waste into mainstream raw materials. Accelerating Circularity has created a working group, the Alliance of Textile Chemical Recyclers (ACTR), to meet and address the textile industry with a common voice to facilitate accurate information on textile chemical recycling.

“We formed this collective to move chemical recycling technology forward, share common definitions, and address policies in a collaborative way to maximize the elimination of textile waste to landfills and incineration” explained Karla Magruder, Founder and President of Accelerating Circularity. “Chemical recycling technology has many benefits, including quality more similar to virgin fiber and the ability to recycle multiple times.”

ACTR plans to provide the industry with information on how textile chemical recycling can:

• offer solutions for diverting textile waste to landfill
• enable textile to textile recycling versus incineration/landfill
• provide sustainably sourced/circular materials
• support brand/retailers/producers in achieving their CO2 reduction targets
• provide long term price stability and consistent supply of raw materials versus virgin

Members of the Alliance include founding members Eastman, Lenzing, and The LYCRA Company, as well as key innovators Circ®, Sappi, Renewcell, Infinited fiber, Worn Again Technologies, Gr3n, CuRe Technology, and OnceMore® from Sodra.

As a first step, the ACTR (Alliance of Chemical Textile Recycling) is introducing a dictionary of common terms developed to educate the industry on the chemical recycling of textiles.

ECHA’s Enforcement Forum agreed to launch an EU-wide project to check that products sold online comply with REACH restrictions and the requirements of the Classification, Labelling and Packaging (CLP) Regulation. Its subgroup on Biocidal Products Regulation, BPRS, agreed to launch a project on labelling of biocidal products.

The Enforcement Forum including its BPR subgroup (BPRS) is a network of enforcement authorities from the EU and EEA. They are responsible for coordinating the enforcement of the REACH, CLP, PIC, POPs and the Biocidal Product Regulations with the aim of protecting our health and the environment while ensuring a level playing field for companies across the EU market.

Inspections in this REACH-EN-FORCE (REF)-13 project will take place in 2025. The objective is to check that products, such as toys, common household goods or chemicals, sold online comply with REACH restrictions. Inspectors will also check that mixtures are classified, labelled and packaged in line with CLP and that online offers include the required information about the hazards of the mixture. Inspectors may also check compliance with restrictions under the Persistent Organic Pollutants (POPs) Regulation and the Restriction of Hazardous Substances (RoHS) Directive.

The online sale of chemicals is an area of high non-compliance. In a previous Forum project (REF-8), inspectors often found that mixtures and articles sold online contained restricted hazardous substances, including those causing cancer. The project found that 78 % of controlled mixtures or articles did not fulfil the conditions of REACH restrictions.

In the upcoming project, inspectors can rely on stricter rules governing online sales, such as the Digital Services Act and General Product Safety Regulation. These new laws are expected to make enforcement stronger.

The Forum’s subgroup on Biocidal Products Regulation (BPRS), agreed that the next major enforcement project on biocides (BEF-3) will focus on controlling the correctness of product labels for biocidal products. Inspectors will check that the information on the labelling of biocides corresponds to that what has been authorised and included in the Summary of Product Characteristics. Inspectors may also check the presence and quality of information in the Safety Data Sheets, where it is required for biocidal products.

Both REF-13 and BEF-3 projects will be prepared in 2024, inspections are planned for 2025 and reports are expected to be published in 2026.

During the meeting, the Forum members elected a new chair and vice chair. Henrik Hedlund (SE) will start as the Forum chair and Katja vom Hofe (DE) and Maria Orphanou (CY) will be the vice chairs as of 21 June 2023. Its biocides subgroup elected Helmut de Vos (BE) as chair and Jenny Karlsson (SE) and Eugen Anwander (AT) as vice chairs.

Freudenberg Performance Materials (Freudenberg) is expanding its product portfolio by adding an elastic variant of its flexible superabsorbers for modern wound dressings. These superabsorbers increase the comfort level for patients as well as enabling longer wear time, thus reducing the frequency of dressing changes. Further highlights at EWMA include components for more sustainable wound care, PU foams with directly applied silicone adhesives, antimicrobial systems and an innovative hydrophilic debridement foam. The global manufacturer will be welcoming visitors to Exhibition Stand from May 3 – 5 at EWMA 2023.

Freudenberg uses a new technology to manufacture the elastic superabsorbers. Unlike other methods, this technology does not perforate or slit the material, thus achieving a high degree of consistent elasticity. Furthermore, the technology used by Freudenberg bonds the superabsorbent fibers more uniformly with the material, thus enhancing the integrity of this layer in the wound dressing.

Further highlights
Freudenberg is also presenting the M 1714 wound pad component, one example of a sustainable solution that simultaneously delivers on performance. The dressing consists of bio-based fibers and exhibits a smooth wound contact layer. M 1714 has been evaluated for industrial compostability and conforms to ISO 13432. This enables certification of product biodegradability. Further highlights to be presented in Milan include material systems for the antimicrobial treatment of chronic wounds, including systems that do not use active substances.

Wound dressing with silicone adhesive border
With Freudenberg’s silicone coated foams, manufacturers can reduce the number of process steps, thereby avoiding waste, saving energy and simplifying the supply chain. Compared with conventional foam dressings, the Freudenberg foam product also offers higher flexibility for optimal wound bed contouring and reduces the risk of infection by preventing exudate pooling. Freudenberg is showcasing the prototype of a bordered dressing with a silicone adhesive border. In addition, the variant with an extra-strong silicone border enables longer wear time while at the same time ensuring minimal adherence to new skin that forms at the wound edges.

More effective cleansing results and greater patient comfort
Freudenberg is also showcasing an innovative hydrophilic debridement foam. It is ideally suited for use in wound cavities, offers better cleansing results and reduced risk as well as greater patient comfort.

• Harmful PFAS chemicals, used in thousands of consumer products, are shaping up to be the big environmental and health threat of our time. The EU is now the first in the world to propose a broad ban on these chemicals.
• Consumer brands worth more than €130 billion support the ban on PFAS.  
• Investors with assets in PFAS-producing companies are calling for an end to production.

Many companies are taking a stand against PFAS chemicals as the EU invites the public to give its opinions on the proposed ban on these harmful chemicals.

108 companies dedicated to phasing out PFAS chemicals from products and processes have joined the PFAS Movement, an advocacy campaign initiated by environmental NGO ChemSec that calls for comprehensive regulation of PFAS in the EU. The members comprise many well-known brands, such as Inditex, Urbanears and the Cookware Company, representing various industries— fashion, home goods, food, and personal care. The members are worth more than €130 billion in total revenue.

“A European ban on PFAS chemicals will have huge repercussions for all manufacturing industries and require much work for companies in the global supply chain. However, some parts of the industry oppose this ban, claiming that the change is too big to be justified. That’s why the support for a ban from such influential consumer brands as those in the PFAS Movement is so important. It’s a strong sign that businesses want to eliminate PFAS chemicals in products and processes”, says Anne-Sofie Bäckar, Executive Director at ChemSec.

A Hollywood Helping Hand
ChemSec’s PFAS Movement is not only supported by the brands but also by Hollywood actor Mark Ruffalo who became a PFAS activist after his involvement in the film Dark Waters. The film depicts the real-life events following the massive uncovering of PFAS contamination in the USA. As a result, several PFAS producers in the USA are now involved in multimillion-dollar lawsuits.

The health and environmental threats of PFAS, along with all the lawsuits, have also created attention among another influential group: institutional investors. Last year, 47 institutional investors with US$8 trillion in assets sent a letter to 54 chemical companies named by ChemSec, calling for them to halt the production of persistent “forever chemicals”.

The EU ban on PFAS
The proposed EU ban on PFAS is extensive and the first of its kind worldwide. The idea was initially initiated by Sweden, Denmark, the Netherlands, Germany and Norway, who have spent almost three years mapping the implications of a ban on PFAS chemicals in a dossier that expands over nearly 2000 pages. The proposal shows, among other things, that the emissions of PFAS were 75 000 tonnes in 2020. If this continues, the emissions are expected to sit at 4.4 million tonnes in 30 years. The emissions originate from the production and use of the many products that contain PFAS; furniture, cosmetics, electronics and many more.

The EU's plans to ban PFAS (per- and polyfluoroalkyl substances) chemicals will have an immense impact on companies globally. Perhaps even more than expected, as many manufacturers are unaware that they may have PFAS chemicals in their product line. A new online tool, launched today by NGO ChemSec, will help to solve this problem.

Just a couple of weeks after the big PFAS restriction proposal in the EU was published, ChemSec launches the PFAS Guide, which helps companies investigate the use of persistent chemicals within their businesses. The main feature of the PFAS Guide is the searchable database uncovering different PFAS uses and functions. The online tool also provides guidance on different aspects of the phase-out process from regulation and investigation all the way to testing and supply chain communication.

“We’ve been working to support companies in chemical substitution for a long time, and the last few years we’ve gathered a group of companies working specifically on the PFAS issue. The discussions with them made it clear to us that a main challenge is understanding if and where in your business you may have PFAS”, says Dr. Anna Lennquist, Project Leader for the PFAS Guide.

PFAS are a source of growing concern
It has been estimated that 95 percent of all manufactured goods rely on some form of industrial chemical process. A large share of the chemicals used in these processes have been linked to adverse impacts on human health and the environment. PFAS are a clear example of this problem. PFAS have been manufactured and used in products such as make-up, non-stick pans, water- and greaseproof textiles, food-packaging materials, and firefighting foam since the 1950s and are still used in a wide variety of products around the world today.

But they are also substances of growing concern due to their problematic properties. Per- and polyfluorinated alkyl substances (PFAS) are a group of several thousand man-made chemicals that accumulate in the environment and cause health impacts for generations. They are, for example, linked to cancer, lung disease, diabetes, reproductive abnormalities and learning difficulties. Since PFAS do not degrade, these “forever chemicals” are now so widespread that is safe to say that every single human being on the planet have detectable levels of these toxic chemicals in their blood.

A couple of weeks ago, a big proposal to restrict PFAS in the EU was published. The five EU Member States behind the proposal submitted a broad restriction proposal that clearly shows the need for the industry to put all resources into phasing out all PFAS substances.

In its 30th year of dedication to safer textiles and leather, OEKO-TEX® has created a new brand identity. The global certifier of textile and leather products and production worked with branding agency Schwitzke ID to build the clear and unified OEKO-TEX® World.

Based on scientific principles, OEKO-TEX® has been promoting transparency in the textile and leather industry for three decades. Transparency is essential for enabling companies and consumers to make responsible decisions. “The new branding reflects the active, solution-oriented and positive approach. With our independent test institutes, we certify to clear, globally uniform criteria, which we communicate openly," says Inga Bleyer, Global Head of Marketing. "Our new look is clear, consistent and transparent."

The most visible change is the new OEKO-TEX® logo, based on a geometric square and an organic circle, which reflect the scientific approach of OEKO-TEX® and the nature it aims to protect. The logo typo is supported by a stylized, organic form reminiscent of natural structures, such as leaves, drops or textile loops. The reduced colour palette highlights the umbrella brand with a new OEKO-TEX® Green plus black and white. A related colour palette supplements communication about OEKO-TEX® products. The product logos are subordinate to the umbrella brand, creating a unified hierarchy.

The lengthy transition period through 2024 considers sustainability. Customers should start the conversion now and may use any existing labels through the end of 2024.

Ascend Performance Materials has purchased a majority stake in California-based Circular Polymers, a recycler of post-consumer, high-performance polymers including polyamide 6 and 66, polypropylene and polyester (PET). The deal provides Ascend with a consistent supply of high-quality PCR materials for its ReDefyne™ sustainable polyamides, launched at K 2022.

Circular Polymers, which as part of the deal is renamed Circular Polymers by Ascend, reclaims and processes post-consumer carpet via a unique technology and has redirected approximately 85 million pounds of waste from landfills into new goods since 2018.

“We are focused on helping our customers reach their sustainability goals and Circular Polymers by Ascend provides materials that offer strong performance with a considerably smaller environmental footprint, compared to other technologies like pyrolysis,” said Phil McDivitt, president and CEO of Ascend. “Since we launched ReDefyne, the demand for our circular products has been significant across all segments of our business, including automotive, consumer, electronics and high-performance fibers and textiles.”

Ascend has a sustainability strategy based on three pillars: empowering people, innovating solutions and operating without compromise. Ascend has committed to reducing its greenhouse gas emissions by 80% by 2030 and recently announced two new efforts to reduce the carbon footprint of its products.

Freudenberg Performance Materials (Freudenberg) has launched an elastic variant of its flexible superabsorbers for modern wound dressings. These superabsorbers increase the comfort level for patients as well as enabling longer wear time, thus reducing the frequency of dressing changes. Freudenberg is debuting the elastic superabsorbers at this year’s Compamed in Düsseldorf, from November 14 – 17, 2022. Further highlights at the trade fair include components for more sustainable wound care, PU foams with directly applied silicone adhesives, and an innovative hydrophilic debridement foam.

Freudenberg uses a new technology to manufacture the elastic superabsorbers. Unlike other methods, this technology does not perforate or slit the material, thus achieving a high degree of consistent elasticity. Furthermore, the technology used by Freudenberg bonds the superabsorbent fibers more uniformly with the material, thus enhancing the integrity of this layer in the wound dressing.

“Our new elastic superabsorbers demonstrate yet again how Freudenberg components help increase comfort for patients, reduce the workload for nursing staff and lower healthcare costs. Our extensive technology platform and our innovative strength are the basis for this,” Dr. Henk Randau, SVP and General Manager Global Division Healthcare at Freudenberg Performance Materials, said.